Factor Xa Induces Tissue Factor Expression in Endothelial Cells by P44/42 MAPK and NF-κB-Dependent Pathways

被引:22
|
作者
Jiang, Rong [1 ]
Wang, Ning-Ping [2 ]
Tanaka, Kenichi A. [3 ]
Levy, Jerrold H. [3 ]
Guyton, Robert A. [1 ]
Zhao, Zhi-Qing [2 ]
Vinten-Johansen, Jakob [1 ]
机构
[1] Emory Univ, Hosp Midtown, Cardiothorac Res Lab, Carlyle Fraser Heart Ctr,Div Cardiothorac Surg, Atlanta, GA 30322 USA
[2] Mercer Univ, Sch Med Savannah Campus, Dept Biomed Sci, Atlanta, GA USA
[3] Emory Univ, Dept Anesthesiol, Atlanta, GA 30322 USA
关键词
endothelial cell; factor Xa; MAP kinase; NF-kappa B; tissue factor; ACUTE MYOCARDIAL-INFARCTION; COAGULATION-FACTOR XA; SMOOTH-MUSCLE-CELLS; CYTOKINE PRODUCTION; FACTOR GENE; REPERFUSION; THROMBIN; ACTIVATION; INHIBITION; INDUCTION;
D O I
10.1016/j.jss.2010.01.041
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Tissue factor (TF) is an initiator of coagulation. The serine protease factor Xa (FXa) is the convergence point of the extrinsic and intrinsic components of the coagulation cascade. In addition to its hemostatic function, FXa elicits inflammatory responses in endothelial cells that may be important in surgical procedures in which inflammation is triggered. This study tested the hypothesis that FXa can up-regulate TF on vascular endothelial cells by a mitogen-activated protein kinase (MAPK)- and NF-kappa B-dependent pathway. Methods and Results. Incubation of cultured human umbilical vein endothelial cells (HUVECs) with FXa increased TF protein expression and activity in a dose-dependent manner. Pre-incubation of HUVECs with the serine protease inhibitor antithrombin, which targets not only thrombin but also FXa and FIXa, inhibited FXa-induced TF expression, but the selective thrombin inhibitor hirudin did not inhibit FXa-induced TF expression, ruling out a thrombin-mediated pathway. After 10 min incubation with HUVECs, FXa rapidly induced P44/42 MAPK activation (immunoblotting of phosphorylated P44/42 MAPK) with a peak at 30 min. The MEK 1/2 inhibitor PD98059 partially reduced FXa-induced TF expression and activity (3.82 +/- 0.11 vs 6.54 +/- 0.08 fmol/min/cm(2), P < 0.05). NF-kappa B was activated by FXa, confirmed by cytoplasmic IkB alpha degradation and increased NF-kappa B P65 nuclear translocation. Interruption of the NF-kappa B pathway by the IkB alpha phosphorylation inhibitor Bay 11-7802 abrogated FXa-induced TF protein expression and activity (1.93 +/- 0.02 versus 6.54 +/- 0.08 fmol/min/cm(2), P < 0.05). However, inhibition of PI3 kinase by LY 294002 did not attenuate FXa-induced TF protein expression and activity. Conclusions. (1) FXa up-regulates TF protein expression and activity in HUVECs, (2) FXa-induced up-regulation of TF is independent of the thrombin-PAR1 pathway, and (3) the MAPK and NF-kappa B pathways, but not PI3 kinase pathway, are involved in FXa-induced TF expression on human umbilical endothelial cells. FXa may be a feed-forward alternative mechanism of activating TF expression and activity, thereby increasing a procoagulant state or inflammation. This mechanism may be important in the pro-inflammatory state initiated by cardiac surgical procedures. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:319 / 327
页数:9
相关论文
共 50 条
  • [21] NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
    Mendez, Jonathan M.
    Keestra-Gounder, A. Marijke
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2020, (155):
  • [22] Thrombin induces the expression of tissue factor in human aortic endothelial cells
    Wang, Huang-Joe
    Huang, Huey-Chun
    Chuang, Yi-Ching
    Huang, Haimei
    ACTA CARDIOLOGICA SINICA, 2008, 24 (03) : 151 - 156
  • [23] Arsenic modulates heme oxygenase-1, interleukin-6, and vascular endothelial growth factor expression in endothelial cells: roles of ROS, NF-κB, and MAPK pathways
    Wang, Lisu
    Kou, Mei-Chun
    Weng, Ching-Yi
    Hu, Ling-Wei
    Wang, Ying-Jan
    Wu, Ming-Jiuan
    ARCHIVES OF TOXICOLOGY, 2012, 86 (06) : 879 - 896
  • [24] High-mobility group box 1 protein induces tissue factor expression in vascular endothelial cells via activation of NF-κB and Egr-1
    Lv, Ben
    Wang, Haichao
    Tang, Yiting
    Fan, Zhang
    Xiao, Xianzhong
    Chen, Fangping
    THROMBOSIS AND HAEMOSTASIS, 2009, 102 (02) : 352 - 359
  • [25] Tumor Necrosis Factor Disrupts Claudin-5 Endothelial Tight Junction Barriers in Two Distinct NF-κB-Dependent Phases
    Clark, Paul R.
    Kim, Richard K.
    Pober, Jordan S.
    Kluger, Martin S.
    PLOS ONE, 2015, 10 (03):
  • [26] Mycobacterium leprae induces NF-κB-dependent transcription repression in human Schwann cells
    Pereira, RMS
    Calegari-Silva, TC
    Hernandez, MO
    Saliba, AM
    Redner, P
    Pessolani, MCV
    Sarno, EN
    Sampaio, EP
    Lopes, UG
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 335 (01) : 20 - 26
  • [27] Thrombin Down-Regulates Tissue Factor Pathway Inhibitor Expression in a PI3K/Nuclear Factor-κB-Dependent Manner in Human Pleural Mesothelial Cells
    Jeffers, Ann
    Owens, Shuzi
    Koenig, Kathleen
    Quaid, Brandon
    Pendurthi, Usha R.
    Rao, Vijaya M.
    Idell, Steven
    Tucker, Torry A.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2015, 52 (06) : 674 - 682
  • [28] Analysis of expression of nuclear factor κB (NF-κB) in multiple myeloma:: downregulation of NF-κB induces apoptosis
    Ni, H
    Ergin, M
    Huang, Q
    Qin, JZ
    Amin, HM
    Martinez, RL
    Saeed, S
    Barton, K
    Alkan, S
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (02) : 279 - 286
  • [29] Targeted adenovirus mediated inhibition of NF-κB-dependent inflammatory gene expression in endothelial cells in vitro and in vivo
    Kuldo, J. M.
    Asgeirsdottir, S. A.
    Zwiers, P. J.
    Bellu, A. R.
    Rots, M. G.
    Schalk, J. A. C.
    Ogawara, K. I.
    Trautwein, C.
    Banas, B.
    Haisma, H. J.
    Molema, G.
    Kamps, J. A. A. M.
    JOURNAL OF CONTROLLED RELEASE, 2013, 166 (01) : 57 - 65
  • [30] Urotensin II promotes the proliferation of endothelial progenitor cells through p38 and p44/42 MAPK activation
    Xu, Shengkai
    Wen, Huazhi
    Jiang, Hong
    MOLECULAR MEDICINE REPORTS, 2012, 6 (01) : 197 - 200